BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$140M |
| 2 |
iShares US Financials ETF
IYF
|
+$119M |
| 3 |
AGN
Allergan plc
AGN
|
+$100M |
| 4 |
Charter Communications
CHTR
|
+$95.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$82.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$909M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.73% |
| 2 | Financials | 5.47% |
| 3 | Healthcare | 4.96% |
| 4 | Consumer Discretionary | 4.64% |
| 5 | Industrials | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
QuidelOrtho
QDEL
$1.02B
| $376K | ﹤0.01% |
5,010
-1,352
| -21% | -$87.3K |
|
2527
Standex International
SXI
$4B
| $376K | ﹤0.01% |
4,735
+2,438
| +106% | +$185K |
|
2528
Gerdau
GGB
$9.48B
| $375K | ﹤0.01% |
96,343
-749,927
| -89% | -$2.23M |
|
2529
Artisan Partners
APAM
$2.97B
| $374K | ﹤0.01% |
11,581
+2,688
| +30% | +$77.6K |
|
2530
AutoNation
AN
$6.9B
| $374K | ﹤0.01% |
7,694
-730
| -9% | -$37K |
|
2531
CALL
Cboe Global Markets
CBOE
$30.4B
| $372K | ﹤0.01% |
+31
| New | +$3.64K |
|
|
FOLD
2532
DELISTED
Amicus Therapeutics
FOLD
| $370K | ﹤0.01% |
38,014
-7,352
| -16% | -$67.3K |
|
2533
PUT
iShares MSCI Brazil ETF
EWZ
$8.55B
| $370K | ﹤0.01% |
78
| – | – |
|
|
CORE
2534
DELISTED
Core Mark Holding Co., Inc.
CORE
| $370K | ﹤0.01% |
13,595
+4,714
| +53% | +$131K |
|
2535
CALL
Citizens Financial Group
CFG
$31.1B
| $370K | ﹤0.01% |
+91
| New | +$3.41K |
|
2536
Astec Industries
ASTE
$994M
| $369K | ﹤0.01% |
8,793
+4,722
| +116% | +$171K |
|
2537
MACOM Technology Solutions
MTSI
$23.5B
| $369K | ﹤0.01% |
13,869
+5,237
| +61% | +$125K |
|
2538
Smith & Wesson
SWBI
$636M
| $369K | ﹤0.01% |
51,686
+14,277
| +38% | +$87K |
|
2539
PUT
American Electric Power
AEP
$67.9B
| $369K | ﹤0.01% |
39
| – | – |
|
2540
A10 Networks
ATEN
$2B
| $368K | ﹤0.01% |
53,498
+44,987
| +529% | +$303K |
|
2541
Acushnet Holdings
GOLF
$5.2B
| $367K | ﹤0.01% |
11,303
+3,603
| +47% | +$107K |
|
|
GCP
2542
DELISTED
GCP Applied Technologies Inc.
GCP
| $367K | ﹤0.01% |
16,156
+5,492
| +52% | +$118K |
|
2543
Hecla Mining
HL
$11.9B
| $366K | ﹤0.01% |
108,027
-413,149
| -79% | -$1.01M |
|
|
FOE
2544
DELISTED
Ferro Corporation
FOE
| $365K | ﹤0.01% |
24,594
+9,599
| +64% | +$124K |
|
|
PRSU
2545
Pursuit Attractions and Hospitality Inc
PRSU
$1.27B
| $363K | ﹤0.01% |
5,384
+2,164
| +67% | +$140K |
|
2546
Heartland Express
HTLD
$950M
| $363K | ﹤0.01% |
17,252
+8,840
| +105% | +$189K |
|
|
SAFE
2547
Safehold
SAFE
$1.09B
| $362K | ﹤0.01% |
5,123
+1,923
| +60% | +$122K |
|
2548
Trinity Industries
TRN
$2.3B
| $360K | ﹤0.01% |
16,254
-1,873
| -10% | -$38.2K |
|
2549
National Vision
EYE
$1.54B
| $360K | ﹤0.01% |
11,096
-3,071
| -22% | -$84.4K |
|
2550
Moderna
MRNA
$25.4B
| $360K | ﹤0.01% |
18,393
+10,140
| +123% | +$180K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2019 Portfolio in Review
As of Q4 2019, BNP Paribas Financial Markets held 4,613 positions worth $54.9B, down 2.5% from $56.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.1B in Q4 2019, closing 185 positions and reducing 1,420 holdings. Its most notable exit was Celgene Corp, an estimated $56.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.3% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares US Financials ETF worth $124M.
- BNP Paribas Financial Markets's largest Q4 2019 buy was iShares US Financials ETF: 1,800,000 shares worth $124M.
- BNP Paribas Financial Markets added most to Bristol-Myers Squibb in Q4 2019, an estimated $140M increase.
- BNP Paribas Financial Markets's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Celgene Corp in Q4 2019, selling an estimated $56.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $54.9B portfolio in Q4 2019.
- BNP Paribas Financial Markets opened 106 new positions and closed 185 in Q4 2019.
- BNP Paribas Financial Markets's portfolio value fell 2.5% quarter-over-quarter to $54.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.